Molecular Devices products to be supplied and serviced by Bio-Strategy

Tuesday, 26 May, 2009

After 1 June, Molecular Devices products (previously supplied by MDS Analytical Technologies) will be supplied, serviced and supported by Bio-Strategy in both Australia and New Zealand.

Most of MDS Analytical Technologies' Australian employees have joined Bio-Strategy, and instrument warranties and ongoing service agreements have also been transferred to Bio-Strategy.

For any concerns or questions regarding this transition, Bio-Strategy can be contacted on:
Free phone: 1800 00 84 53
Email: info@bio-strategy.com
Web: www.bio-strategy.com

DKSH brings Bioyond Robotics' lab automation products Down Under

DKSH will provide distribution of the Bioyond Robotics portfolio of AI-driven autonomous...

Immunologist wins GSK Award for respiratory virus research

Award winner Professor Katherine Kedzierska seeks to answer an important question: why do some...

ATSE names Jane O'Dwyer as its new CEO

O'Dwyer is an executive leader with more than 30 years' experience across higher...

Content from other channels on our network

A new national approach to clinical governance

Opinion: The debate over the government's aged care algorithm is missing the point

Commonwealth Home Support Program extended to 30 June 2029

When Connectivity Becomes Critical Care — Webinar

Unregistered doctor convicted after patient is hospitalised following medical procedure

UTS pilot project to mitigate methane emissions

Government invests $1.5m in regional science partnerships

Desalination marine works conclude at Belmont

Zip Water releases 2025 Sustainability Report

Australia's EV fleet transition will be won or lost at the depot

Asahi to use recycled material for all plastic soft drink bottles

Applications open in WA for submarine sustainment contracts

Construction begins on WA gallium project

Latest AEMO report on future grid stability released

UNSW engineers awarded grant for critical renewables research